BridgeBio Pharma, Inc. (BBIO)
73.28
+1.61
(+2.25%)
USD |
NASDAQ |
Apr 24, 16:00
73.32
+0.04
(+0.05%)
After-Hours: 20:00
BridgeBio Pharma Profit Margin (Quarterly) : -126.2% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Pfizer Inc. | -9.34% |
| Mirum Pharmaceuticals, Inc. | -3.85% |
| Insmed, Inc. | -124.5% |
| Eli Lilly & Co. | 34.40% |
| Vanda Pharmaceuticals, Inc. | -246.8% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -76.10% |
| Return on Invested Capital | -96.35% |
| Gross Profit Margin (Quarterly) | 94.27% |
| Operating Margin (Quarterly) | -83.30% |
| Return on Net Operating Assets | -502.5% |